NO20021255D0 - Nye cellecykel-sjekkpunktsgener og proteiner kodet derav - Google Patents

Nye cellecykel-sjekkpunktsgener og proteiner kodet derav

Info

Publication number
NO20021255D0
NO20021255D0 NO20021255A NO20021255A NO20021255D0 NO 20021255 D0 NO20021255 D0 NO 20021255D0 NO 20021255 A NO20021255 A NO 20021255A NO 20021255 A NO20021255 A NO 20021255A NO 20021255 D0 NO20021255 D0 NO 20021255D0
Authority
NO
Norway
Prior art keywords
cell cycle
proteins encoded
cycle checkpoint
new cell
checkpoint genes
Prior art date
Application number
NO20021255A
Other languages
English (en)
Other versions
NO20021255L (no
Inventor
Paul R Russell
Jorge E Vialard
Michael N Boddy
Paul A Shanahan
Antonia Lopez-Girona
Cecile-Marie D D Denis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20021255D0 publication Critical patent/NO20021255D0/no
Publication of NO20021255L publication Critical patent/NO20021255L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20021255A 1999-09-14 2002-03-13 Nye cellecykelsjekkpunktsgener og proteiner kodet derav NO20021255L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15383699P 1999-09-14 1999-09-14
PCT/US2000/025278 WO2001020038A1 (en) 1999-09-14 2000-09-14 Novel cell cycle checkpoint genes and proteins encoded thereby

Publications (2)

Publication Number Publication Date
NO20021255D0 true NO20021255D0 (no) 2002-03-13
NO20021255L NO20021255L (no) 2002-05-03

Family

ID=22548950

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021255A NO20021255L (no) 1999-09-14 2002-03-13 Nye cellecykelsjekkpunktsgener og proteiner kodet derav

Country Status (15)

Country Link
US (3) US6440732B1 (no)
EP (1) EP1214453B1 (no)
JP (1) JP4871468B2 (no)
KR (2) KR100851511B1 (no)
AT (1) ATE404693T1 (no)
AU (1) AU784443B2 (no)
CA (1) CA2385266C (no)
DE (1) DE60039895D1 (no)
DK (1) DK1214453T3 (no)
ES (1) ES2311472T3 (no)
IL (2) IL148595A0 (no)
NO (1) NO20021255L (no)
NZ (1) NZ518236A (no)
WO (1) WO2001020038A1 (no)
ZA (1) ZA200202863B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003298921A1 (en) * 2002-12-04 2004-06-23 Algos Therapeutics, Inc. Methods and materials for modulating trpm2
US7396669B2 (en) * 2004-06-30 2008-07-08 The Scripps Research Institute Mammalian endonucleases and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801154A (en) * 1993-10-18 1998-09-01 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of multidrug resistance-associated protein
US5552390A (en) * 1993-12-09 1996-09-03 The Board Of Regents Of The University Of Nebraska Phosphorothioate inhibitors of metastatic breast cancer
AU6764398A (en) * 1997-03-20 1998-10-12 Variagenics, Inc. Target genes for allele-specific drugs
US5977341A (en) * 1998-11-20 1999-11-02 Isis Pharmaceuticals Inc. Antisense modulation of inhibitor-kappa B kinase-beta expression
US7396669B2 (en) * 2004-06-30 2008-07-08 The Scripps Research Institute Mammalian endonucleases and methods of use

Also Published As

Publication number Publication date
DE60039895D1 (de) 2008-09-25
US7214790B2 (en) 2007-05-08
EP1214453B1 (en) 2008-08-13
KR20020064781A (ko) 2002-08-09
AU7581700A (en) 2001-04-17
CA2385266C (en) 2011-05-24
US20070072794A1 (en) 2007-03-29
ZA200202863B (en) 2003-09-23
KR20070043872A (ko) 2007-04-25
JP4871468B2 (ja) 2012-02-08
JP2003509069A (ja) 2003-03-11
IL148595A (en) 2008-11-26
CA2385266A1 (en) 2001-03-22
ES2311472T3 (es) 2009-02-16
AU784443B2 (en) 2006-04-06
KR100817010B1 (ko) 2008-03-27
EP1214453A1 (en) 2002-06-19
NZ518236A (en) 2004-02-27
NO20021255L (no) 2002-05-03
DK1214453T3 (da) 2008-10-13
US7479541B2 (en) 2009-01-20
KR100851511B1 (ko) 2008-08-11
IL148595A0 (en) 2002-09-12
WO2001020038A1 (en) 2001-03-22
ATE404693T1 (de) 2008-08-15
US6440732B1 (en) 2002-08-27
EP1214453A4 (en) 2003-02-19
US20070213256A1 (en) 2007-09-13

Similar Documents

Publication Publication Date Title
ES2177475T1 (es) Genes de corynebacterium glutamicum que codifican proteinas de una ruta metabolica.
DE60235039D1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
EP1824977A4 (en) NOVEL PROMOTER NUCLEIC ACID FROM CORYNEBACTERIUM GENE BACTERIUM, EXPRESSION CASSETTE CONTAINING THE PROMOTER AND VECTOR CONTAINING THE CASSETTE, HOST CELL COMPRISING THE VECTOR, AND METHOD FOR EXPRESSION OF A GENE USING THE CELL
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
DE69534733D1 (de) NEUARTIGE AUF p53 ANSPRECHENDE GENE
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
DE60033138D1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
DE60328715D1 (de) Polypeptide mit cellobiohydrolase ii-aktivität und dafür kodierende polynucleotide
BR9813608B1 (pt) célula hospedeira de bacillus transgênica, e, processo para produzir um polipeptìdeo tendo atividade aminopeptidase.
ATE488591T1 (de) Neuer l-lysin-induzierbarer promotor
DK2386319T3 (da) Promotere, der udviser endothelcellespecificitet og fremgangsmåder til anvendelse heraf
NO20021255L (no) Nye cellecykelsjekkpunktsgener og proteiner kodet derav
ZA200404424B (en) Genes encoding for genetic stability, gene expression and folding proteins.
DE60139113D1 (de) 18477, eine menschliche proteinkinase und deren verwendung
WO2003066867A3 (en) Genetically engineered phic31-integrase genes
DK1032683T3 (da) Polypeptider med 5-aminolevulinsyre-syntase-aktivitet og nukleinsyrer, der koder for disse
WO2004029233A3 (en) Mutant recombinases
WO2003104449A3 (en) IMPROVEMENTS IN PROTEIN PRODUCTION
DK1226236T3 (da) Polypeptider, der har glucanotransferase-aktivitet, og nucleinsyrer, som koder disse
ATE547427T1 (de) Verfahren zur rekombinanten herstellung von ribonukleoproteinen
NO971359L (no) Humant galaktokinase-gen
WO2005017176A3 (en) Methods for identifying risk of melanoma and treatments thereof
DE69840051D1 (de) Durch wnt-1 induzierbare gene
CO5400145A1 (es) Proteina asociada con enfermedad
TR200707453T2 (tr) Karbon metabolizma ve enerji üretimindeki proteinleri kodlayan corynebacterıum glutamicum genleri.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application